D. Yu. Belousov

Considerations for the design and conduct of externally controlled trials for drug and biological products

A. S. Motrinchuk, D. Yu. Belousov · Real-World Data & Evidence · 2023 · 44 citations · Full text

Real-world Evidence, Agency Guidance, Clinical Trials +19

Assessing routine healthcare pattern for type 2 diabetes mellitus in Russia: the results of рharmacoepidemiological study (FORSIGHT-DM2)

Marina Kalashnikova, D. Yu. Belousov, Vladimir Rafalskiy et al. · Diabetes Mellitus · 2016 · 29 citations · Full text

Russian Federation, рHarmacoepidemiological Study, Metabolic Syndrome +17

RESULTS OF PHARMACOEPIDEMIOLOGIC STUDY OF ARTERIAL HYPERTENSION PIFAGOR IV: PHYSICIANS COMPLIANCE

Lotti Steinberg, Yu. B. Belousov, D. V. Belyavskaya et al. · Russian Journal of Cardiology · 2015 · 24 citations · Full text

Hypertension, Cardiovascular Pharmacology, Pharmacotherapy +22

Cost-of-Illness Analysis of Type 2 Diabetes Mellitus in the Russian Federation: Results from Russian multicenter observational pharmacoepidemiologic study of diabetes care for patients with type 2 diabetes mellitus (FORSIGHT-Т2DM)

Marina Kalashnikova, D. Yu. Belousov, Vladimir Rafalskiy et al. · Diabetes Mellitus · 2018 · 23 citations · Full text

Total Cost, Russian Federation, Health Care Finance +17

Review of real-world data study

T.A. Goldina, D. Yu. Belousov, V. G. Borovskaya · Kachestvennaya Klinicheskaya Praktika = Good Clinical Practice · 2021 · 15 citations · Full text

Engineering, Real-world Data, Real-world Evidence +22